EMPERRA GMBH E-HEALTH TECHNOLOGIES

Company Snapshot

Founded: 2008
Entity Type: Private
Region: Germany
Headquarter: Potsdam, Germany
Key Geographics: Europe
Corporate Address: Zeppelinstrasse 48a D – 14471 Potsdam Germany Tel. +49-331-979-3480-0 www.emperra.com

Company Overview

Emperra GmbH E-Health Technologies offers e-health technologies and tele diabetology for patients with diabetes mellitus. Its Esysta pen is a smart insulin pen that is compatible with all major insulin brands. At the forefront of its offerings is the Esysta system, a diabetes management platform encompassing a blood glucose meter, insulin pen, data transfer station and online portal. The Esysta system enables individuals with diabetes to monitor their blood glucose levels, insulin dosage and carbohydrate intake and facilitating the sharing of this vital data with their healthcare providers.

Features of the Esysta system include automatic data recording and data sharing. The system automatically captures and logs blood glucose levels, insulin dosage and carbohydrate intake. This data can be accessed through the Esysta blood glucose meter, the Esysta data transfer station or the Esysta online portal. The system allows individuals with diabetes to collaborate with their healthcare providers, a collaborative approach that supports well-informed treatment decisions.

EMPERRA GMBH E-HEALTH TECHNOLOGIES In Reports

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

BCC Research Market Analyst says global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028 at a CAGR of 9.8%.

Continuous Glucose Monitoring (CGM): Technologies and Global Markets

BCC Research Market Report for Continuous Glucose Monitoring Market. key factors driving the growth of the CGM market covering top player Abbott Laboratories, F.Hoffman-la Roche, LifeScan, Medtronic, Dexcom, and...

Smartphone-Based Patient Monitoring: Global Market

BCC Research Market Report for Smart Phone Based Patient Monitoring industry. Global smartphone-based patient monitoring market study includes the market size analysis and a detailed analysis of the market player’s...

Company's Business Segments

  • Diabetes Management Solutions : This segment includes Compatible Blood Glucose Monitoring Systems, Compatible Smart Insulin Application Aids through its ESYSTA App, ESYSTA Portal.

Applications/End User Industries

  • Diabetes Patients
  • Healthcare
  • Pharmaceutical
  • Diabetes Management Solutions
  • Insulin Application Aids
AI Sentiment